# TESTOSTERONE CYPIONATE
> **ANDA215351** · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2023-04-13
## Drug
- **FDA Application Number:** ANDA215351
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TESTOSTERONE CYPIONATE
- **Generic name:** TESTOSTERONE CYPIONATE
- **Active ingredients:** TESTOSTERONE CYPIONATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** XIROMED
- **Manufacturer:** NorthStar Rx LLC
- **First approval:** 2023-04-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215351)
---
*MORVS · CC0 1.0*